HomeCompareNVMLF vs JNJ

NVMLF vs JNJ: Dividend Comparison 2026

NVMLF yields 40.00% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 NVMLF wins by $211.8K in total portfolio value
10 years
NVMLF
NVMLF
● Live price
40.00%
Share price
$5.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$231.9K
Annual income
$39,181.04
Full NVMLF calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — NVMLF vs JNJ

📍 NVMLF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodNVMLFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, NVMLF + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
NVMLF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

NVMLF
Annual income on $10K today (after 15% tax)
$3,400.00/yr
After 10yr DRIP, annual income (after tax)
$33,303.88/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, NVMLF beats the other by $32,600.27/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of NVMLF + JNJ for your $10,000?

NVMLF: 50%JNJ: 50%
100% JNJ50/50100% NVMLF
Portfolio after 10yr
$125.9K
Annual income
$20,004.41/yr
Blended yield
15.88%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

NVMLF
No analyst data
Altman Z
182.0
Piotroski
3/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

NVMLF buys
0
JNJ buys
0
No recent congressional trades found for NVMLF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricNVMLFJNJ
Forward yield40.00%3.36%
Annual dividend / share$2.00$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$231.9K$20.0K
Annual income after 10y$39,181.04$827.78
Total dividends collected$174.4K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: NVMLF vs JNJ ($10,000, DRIP)

YearNVMLF PortfolioNVMLF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$14,700$4,000.00$10,676$355.77+$4.0KNVMLF
2$21,224$5,495.33$11,407$389.39+$9.8KNVMLF
3$30,125$7,415.26$12,198$426.53+$17.9KNVMLF
4$42,071$9,836.48$13,056$467.62+$29.0KNVMLF
5$57,854$12,838.17$13,987$513.12+$43.9KNVMLF
6$78,403$16,499.54$14,998$563.56+$63.4KNVMLF
7$104,788$20,897.28$16,098$619.52+$88.7KNVMLF
8$138,226$26,102.79$17,295$681.69+$120.9KNVMLF
9$180,082$32,179.61$18,599$750.82+$161.5KNVMLF
10$231,869$39,181.04$20,022$827.78+$211.8KNVMLF

NVMLF vs JNJ: Complete Analysis 2026

NVMLFStock

Navarre Minerals Limited explores for develops mineral properties in Australia. The company primarily produces copper, gold, silver, lead, and zinc, as well as volcanic massive sulphide deposits. Its flagship property is the 100% owned Stawell Corridor gold project located near Victoria; and Mt Carlton project, which covers an area of 815 square kilometers situated near Townsville, Queensland. Navarre Minerals Limited was incorporated in 2007 and is based in Stawell, Australia.

Full NVMLF Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this NVMLF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

NVMLF vs SCHDNVMLF vs JEPINVMLF vs ONVMLF vs KONVMLF vs MAINNVMLF vs ABBVNVMLF vs MRKNVMLF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.